Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

NephRx Awarded U.S. Patent for Oral Mucositis Agent

March 23, 2011 7:15 am | News | Comments

NephRx Corporation announced the issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.

TOPICS:

Pozen Inks Deal with J & J Company for Migraine Drug

March 23, 2011 7:13 am | News | Comments

Pozen Inc. announced a deal with Johnson & Johnson's Cilag GmbH International division to make and sell its migraine drug in South America. Pozen said Cilag will sell its drug, MT 400, in Brazil, Colombia, Ecuador and Peru.

TOPICS:

Ophthalmology Drug Achieves Co-Primary Endpoints

March 23, 2011 7:08 am | News | Comments

OMS302 is Omeros' pharmacosurgery product in development to maintain intra-operative mydriasis (pupil dilation) and reduce postoperative pain and irritation resulting from cataract and other lens replacement surgery.

TOPICS:
Advertisement

Hi-Tech Pharmacal Gains Approval, New ANDA

March 23, 2011 7:04 am | News | Comments

Hi-Tech Pharmacal Co., Inc. announced that the U.S. Food and Drug Administration, granted final approval for its Abbreviated New Drug Application, for ranitidine syrup 15mg/mL, the generic for GlaxoSmithKline's Zantac syrup.

TOPICS:

Filling System

March 22, 2011 8:07 am | Product Releases | Comments

The RingDex is a filling system with a unique modular design that will greatly improve previously manual & tedious filling / capping operations. Unlike traditional filling systems, the RingDex allows quick changeovers for low to medium volume production.

TOPICS:

Electronic Pipette

March 22, 2011 8:01 am | Product Releases | Comments

The INTEGRA VIAFLO 96 is a 96-channel electronic pipette that enables fast, precise and easy simultaneous transfer of 96 samples. The VIAFLO 96 has been designed to be used just like a standard handheld pipette.

TOPICS:

Supercritical Fluid Extractor

March 22, 2011 7:57 am | Product Releases | Comments

Supercritical Fluid Technologies introduces a benchtop supercritical fluid extractor, the SFT-110XW. The completely redesigned restrictor valve with integrated micrometer allows for very precise flow control, which is essential for demanding applications.

TOPICS:

Blowdown Evaporator

March 22, 2011 7:54 am | Product Releases | Comments

The MiniVap Blowdown Evaporator from Porvair Sciences takes just minutes to remove volatile organic solvents from your HPLC fractions collected in 24- or 96-well microplates.

TOPICS:
Advertisement

Merck to Acquire Biotest

March 22, 2011 7:50 am | News | Comments

Merck KGaA announced that it has entered into a definitive agreement to acquire the microbiology business of Biotest AG. The business has approximately 290 employees and sales of approximately €50 million in 2010.

TOPICS:

Senectus Working On AstraZeneca Library

March 22, 2011 7:39 am | News | Comments

Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca’s chemical compound library to identify those which trigger a key element of cancer cell ageing – called senescence.

TOPICS:

Provectus Holds Meeting with FDA

March 22, 2011 7:36 am | News | Comments

Provectus Pharmaceuticals, Inc. has held its second end-of-Phase 2 meeting with the U.S. Food and Drug Administration. The meeting addressed the company’s planned pivotal Phase 3 randomized controlled trial of PV-10 for metastatic melanoma.

TOPICS:

Ipilimumab Improves Melanoma Survival Time

March 22, 2011 7:29 am | News | Comments

Bristol-Myers Squibb Co. said that a new study of its highly anticipated melanoma drug improved survival time in patients with advanced skin cancer.

TOPICS:

Cephalon Acquiring Gemin X for $225M

March 22, 2011 7:25 am | News | Comments

Cephalon Inc. said it will acquire privately held Gemin X Pharmaceuticals Inc. for $225 million in an all-cash deal aimed at bolstering Cephalon's lineup of cancer treatments.

TOPICS:

Merck-Sanofi Animal Health Deal Collapses

March 22, 2011 7:24 am | News | Comments

Drugmakers Merck & Co. and Sanofi-Aventis SA on abandoned a year-old effort to create a veterinary medicine joint venture because of the deal's mounting complexity and regulatory hurdles.

TOPICS:

New Breakthrough in Fatal Genetic Ailment

March 22, 2011 7:21 am | News | Comments

A paper detailing an important discovery in Niemann-Pick Type C shows how use of a histone deacetylase inhibitor corrects the damage done by the genetic disorder and allows once-diseased cells to function normally.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading